Log in or Sign up for Free to view tailored content for your specialty!
Gastroenterology News
Gastroenterologists should ‘start to own,’ embrace role in care for chronic liver disease
Chronic liver disease is the ninth leading cause of death in the United States, independent of liver cancer. According to the CDC, only 1.8% of adult Americans have a diagnosis of chronic liver disease, which translates to 4.5 million people.
‘Not simply a hand-off’: GIs, hepatologists have critical role in HCC care after diagnosis
The role of gastroenterologists and hepatologists in the management of patients at risk for or with hepatocellular carcinoma is multifold.
Log in or Sign up for Free to view tailored content for your specialty!
MASLD requires multidisciplinary care to ‘improve global metabolic, liver health’
Finding adequate providers with the expertise to treat the growing population of patients with chronic liver diseases, including metabolic dysfunction-associated steatotic liver disease, is a challenging but important endeavor.
Early intervention critical, before ‘significant clinical toll’ from excessive alcohol use
Alcohol use disorder has a huge impact on liver health. Regardless of whether patients have other primary etiology for liver disease, alcohol — even in minimal amounts — can worsen liver outcomes.
‘All hands on deck’: GIs should continue to be part of viral hepatitis care team
Primary care providers and other specialists often refer patients to gastroenterologists with any liver-related health concerns, as they are the first touch point for newly diagnosed patients or those living with chronic liver disease.
GIs ‘should still care about hepatology’ as workforce shortage, disease burden rise
In 2020, a model in Hepatology projected an impending “critical shortage” of adult and pediatric hepatology providers in the U.S., posing a potential challenge as an increasing number of individuals are expected to present for care.
BLOG: If sitting is the new smoking, should apps have warnings like cigarette packages?
For most of us doctors, it’s the last thing we look at before bed and the first thing when we wake up: the screen of our smartphone or tablet.
FDA grants orphan drug designation to olezarsen for familial chylomicronemia syndrome
The FDA has granted orphan drug designation to Ionis Pharmaceuticals’ olezarsen, an investigational ligand-conjugated antisense drug for the treatment of familial chylomicronemia syndrome, according to a company release.
VIDEO: Proven skills, decision-making help women ‘rise above’ bias in advanced endoscopy
In our latest installment of Healio’s diversity, equity and inclusion series, Aileen Bui, MD, and her mentor, Jennifer Phan, MD, discussed managing gender-based bias in advanced endoscopy and how women can combat impostor syndrome.
Gut microbiome dictates DMARD response in RA; DMARDs partly restore microbiota diversity
Gut microbiota profiles in stool samples of patients with rheumatoid arthritis predicted their response to disease-modifying antirheumatic drugs, according to data in Rheumatology.